Paul-Ehrlich-Institut

Go to:

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Safety Information (human)

From 2020 to 2025

Date Title
31.03.2025 Use Caution Regarding Commercial Treatment Offers of Unauthorised / Unapproved Advanced Therapy Medicinal Products
07.05.2025 Paul-Ehrlich-Institut Permits Import of Two Further Batches Beyfortus with French Labelling
29.11.2024 Information on the Supply of Beyfortus, a Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus (RSV) Infections in the Lower Respiratory Tract
24.07.2024 Monoclonal Antibody Cancer Medicine Oyavas Available in Germany with Hungarian Labelling
27.02.2024 Rabipur available on a limited basis in misprinted German packaging
08.04.2021 COVID-19 Vaccine AstraZeneca – Safety Assessment Result: The Vaccine is Safe and Effective in the Fight against COVID-19
19.03.2021 19 March 2021: Information for Medical Doctors - COVID-19 Vaccine AstraZeneca
16.03.2021 The Paul-Ehrlich-Institut informs - Temporary Suspension of Vaccination with COVID-19 Vaccine AstraZeneca
11.03.2021 COVID-19 Vaccine AstraZeneca
26.05.2020 Warning against the Off-label Use of BCG Products

top